Epigenomics AG (FRA:ECX)

Germany flag Germany · Delayed Price · Currency is EUR
1.100
+0.230 (26.44%)
Last updated: Dec 1, 2025, 9:47 AM CET
-17.91%
Market Cap762.95K
Revenue (ttm)4.00K
Net Income (ttm)-2.76M
Shares Out876.95K
EPS (ttm)-3.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume846
Average Volume142
Open0.880
Previous Close0.870
Day's Range0.880 - 1.100
52-Week Range0.500 - 1.720
Beta0.76
RSI46.12
Earnings DateNov 10, 2025

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, it was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is based in Heidelberg, Germany. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1998
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol ECX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.